Skip to main content
Tech.euFundingExplorerBeta

Opna Bio

Clinical-stage biopharmaceutical company

Total raised
€37M
€36,993,193
Funding rounds
1
Investors
3
distinct backers
Active since
2022-11
latest 2022-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood32
base rate 44% for Series A
  • Overdue vs cohort gap
  • Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2022-11-22Series A€37MLongitude Capital,Menlo Ventures,Northpond VenturesView deal →

Related news

Similar companies

same sector or country